Australia markets open in 2 hours 44 minutes

Aequus Pharmaceuticals Inc. (AQS.V)

TSXV - TSXV Real-time price. Currency in CAD
Add to watchlist
0.0300+0.0100 (+50.00%)
At close: 03:57PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-2,882
-2,965
-3,210
-1,810
-1,045
-
Depreciation & amortisation
136.497
138.163
129.831
128.109
210.966
-
Stock-based compensation
54.151
50.916
40.941
215.757
297.643
-
Change in working capital
78.457
415.076
445.571
28.914
-521.705
-
Accounts receivable
-34.197
278.41
630.982
-161.565
-223.218
-
Inventory
-8.482
-29.923
46.003
-16.504
-117.893
-
Other working capital
-2,549
-2,294
-1,953
-1,176
-817.225
-
Other non-cash items
64.6
66.494
115.525
267.883
253.548
-
Net cash provided by operating activities
-2,549
-2,294
-1,953
-1,172
-804.908
-
Cash flows from investing activities
Investments in property, plant and equipment
-
-
-
-4.121
-12.317
-2.679
Purchases of investments
-
-
0
-503.84
0
-
Net cash used for investing activities
-
-
0
-507.961
-12.317
-2.679
Cash flows from financing activities
Debt repayment
-158.853
-155.633
-2,189
-147.508
-143.827
-
Common stock issued
-
-
0
2,545
2,155
0.22
Net cash used provided by (used for) financing activities
2,747
2,214
-189.187
2,398
2,052
-
Net change in cash
197.863
-79.618
-2,142
717.562
1,234
-
Cash at beginning of period
44.181
249.815
2,392
1,674
484.506
-
Cash at end of period
242.044
170.197
249.815
2,392
1,719
-
Free cash flow
Operating cash flow
-2,549
-2,294
-1,953
-1,172
-804.908
-
Capital expenditure
-
-
-
-4.121
-12.317
-2.679
Free cash flow
-2,549
-2,294
-1,953
-1,176
-817.225
-